Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (7)
- (-) Biomedical (10)
- 3-D Printing/Advanced Manufacturing (26)
- Advanced Reactors (2)
- Big Data (5)
- Bioenergy (13)
- Biology (23)
- Biotechnology (5)
- Buildings (13)
- Chemical Sciences (7)
- Clean Water (8)
- Climate Change (11)
- Composites (6)
- Computer Science (30)
- Coronavirus (10)
- Critical Materials (4)
- Cybersecurity (5)
- Decarbonization (7)
- Energy Storage (22)
- Environment (39)
- Exascale Computing (2)
- Frontier (4)
- Fusion (8)
- Grid (11)
- High-Performance Computing (19)
- Isotopes (12)
- ITER (4)
- Machine Learning (1)
- Materials (32)
- Materials Science (22)
- Mathematics (1)
- Mercury (3)
- Microscopy (10)
- Nanotechnology (10)
- National Security (7)
- Net Zero (1)
- Neutron Science (18)
- Nuclear Energy (6)
- Physics (3)
- Polymers (5)
- Quantum Computing (5)
- Quantum Science (12)
- Security (3)
- Space Exploration (4)
- Statistics (1)
- Summit (9)
- Sustainable Energy (35)
- Transportation (21)
Media Contacts
![Biopsy from the tubular esophagus showing incomplete intestinal metaplasia, goblet cells with interposed cells having gastric foveolar-type mucin consistent with Barrett esophagus. Negative for dysplasia. H&E stain. Credit: Creative Commons](/sites/default/files/styles/list_page_thumbnail/public/2021-11/1200px-Barrett_esophagus_high_mag%5B1%5D_2.jpg?h=10d202d3&itok=qDgHrzu5)
A team including researchers from the Department of Energy’s Oak Ridge National Laboratory has developed a digital tool to better monitor a condition known as Barrett’s esophagus, which affects more than 3 million people in the United States.
![Summer Widner, Stephanie Timbs, James Gaugler and James Avenell of ORNL are part of a team that processes thorium-228, a byproduct of actinium-227. As new uses for thorium are realized, particularly in medicine, the lab expects the demand for the radioisotope to grow.](/sites/default/files/styles/list_page_thumbnail/public/2021-08/Part%20of%20Th-228%20Team_1.jpg?h=09b6d1d3&itok=1_l1hx2l)
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
![Researchers studying secondary metabolites in the fungus Aspergillus flavus, pictured, found unique mixes of metabolites corresponding to genetically distinct populations. The finding suggests local environmental conditions play a key role in secondary metabolite production, influencing the discovery of drugs and other useful compounds. Credit: Tomás Allen Rush/ORNL, U.S. Dept. of Energy.](/sites/default/files/styles/list_page_thumbnail/public/2021-07/DSC0351.jpg?h=b2d9f031&itok=PNgYY5eW)
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/Deborah%20Frincke%20profile_0.jpg?h=8caed45b&itok=0eTC4gMH)
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
![ORNL’s Sergei Kalinin and Rama Vasudevan (foreground) use scanning probe microscopy to study bulk ferroelectricity and surface electrochemistry -- and generate a lot of data. Credit: Jason Richards/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/KalininVasudevan_2017-P03014_0.jpg?h=1116cd87&itok=KEEOB4hi)
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Oak Ridge National Laboratory’s MENNDL AI software system can design thousands of neural networks in a matter of hours. One example uses a driving simulator to evaluate a network’s ability to perceive objects under various lighting conditions. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/CARLA%20MENNDL%20sim001_1.png?h=e2caa22a&itok=tvE9seMo)
The Department of Energy’s Oak Ridge National Laboratory has licensed its award-winning artificial intelligence software system, the Multinode Evolutionary Neural Networks for Deep Learning, to General Motors for use in vehicle technology and design.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.